Vilazodone Hydrochloride Tablet
Product Images NDC 68788-8735

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Vilazodone Hydrochloride (NDC 68788-8735). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

A Yellow Rectangular Object With Black Textdescription Automatically Generated (061efdcc 40ea 4647 8cc8 01cd1ccca68b 00)

The label for Vilazodone HCl Tablets 40 mg, generic for Viibryd, manufactured by MSN Laboratories Pvt. Ltd. The oval blue tablet is imprinted with MV/16. The label includes storage instructions, dosage directions in English and Spanish, and a caution that federal law prohibits drug transfer. The labeler is Preferred Pharmaceuticals Inc. based in Anaheim, California.*

FDA Label Image

Vilazodone-figure1 (Vilazodone Figure1)

A chart illustrating the fold change and 90% confidence interval in Cmax and AUC values of vilazodone hydrochloride when coadministered with ethanol, CYP3A4 inhibitors (ketoconazole), CYP3A4 inducers (carbamazepine), and proton pump inhibitors (pantoprazole). The x-axis represents change relative to reference, ranging from 0.5 to 2.0, and data points show variations in pharmacokinetic parameters due to these substances.*

FDA Label Image

Vilazodone-figure2 (Vilazodone Figure2)

A forest plot chart showing the pharmacokinetic (PK) fold change and 90% confidence intervals for various CYP enzyme and P-glycoprotein substrates relative to a reference. Substrates include nifedipine (CYP3A4), caffeine (CYP1A2), debriquone (CYP2D6), flurbiprofen (CYP2C9), mephenytoin (CYP2C19), and digoxin (P-gp). The chart plots changes for parameters like AUC, Cmax, urinary and plasma recovery ratios, indicating the effect size on drug metabolism or transport.*

FDA Label Image

Vilazodone-figure3 (Vilazodone Figure3)

A fold change and 90% confidence interval chart showing pharmacokinetic parameters (Cmax and AUC) for vilazodone hydrochloride across different populations. Categories include age over 65 years, gender (females), and varying degrees of renal and hepatic impairment (mild, moderate, severe), with data relative to reference groups noted in a footnote.*

FDA Label Image

A Yellow Box With Black Textdescription Automatically Generated (Vilazodone HCl 20mg 30s Cntr Label)

Label of Vilazodone HCl Tablets 20 mg from Preferred Pharmaceuticals Inc., containing each tablet with 20 mg vilazodone HCl. The label includes dosage and storage instructions, manufacturer noted as MSN Laboratories Pvt. Ltd., and warnings about federal drug transfer laws and storage temperatures. The tablet is described as oval, orange, and imprinted with MV / 15.*

FDA Label Image

Vilazodone-str (Vilazodone Str)

Chemical structure diagram of vilazodone hydrochloride, depicting its molecular arrangement for the active ingredient vilazodone hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.